Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Female patients 18 to 45 years old with at least one diagnosed breast fibroadenoma~* Diagnosis of fibroadenoma must be based on:~  * clinical examination~ * ultrasound image alone for patients Under 35 years old. For women older than 35 years, a mammogram will be performed in addition to ultrasound. the BI-RADS score of this mammogram must be less than 3. In all cases where an uncertainly exists, the patient will not be included.~ * histological confirmation after core needle biopsy by two independant readers (biopsy must be performed at least two weeks before therapy unless a micro biopsy has been already done less than 3 months before inclusion visit and histopathology slices are available)~* the requirements for the distance from the skin and the following régions of the fibroadenoma are:~  * depth anterior edge \< 19.4mm~ * nodule thickness \> 7.3 mm~ * depth of posterior edge \> 12.5 mm~ * depth to rib cage \> 10mm~* patient's fibroadenoma size is greater to equal to 0.3 cc (measured by ultrasound on the day of the procedure)~* Lesions should be less than 20 mL~* The lesion must be sonographically visible~* Lesions presented during previous surveillance a minimum 20% increase volume AND/OR~* Patient are presenting a pain level \>= 3 as meaured on the VAS during the last 30 days AND/OR~* Patient are presenting a anxiety level \>= 3 as meaured on the VAS during the last 30 days before selection visit~* Fibroadenoma is palpable~* Patient candidate for sugery~* Patient has signed a written informed consent~* Patient with a social security coverage~Exclusion Criteria:~* Patient is pregnant or lactating~* Patient with history of laser or radiotherapy in the targeted breast~* Core biopsy diagnosis suggestive of cytosarcoma phyllodes tumor or other malignancy~* Patient with breast implant in the targeted breast~* Patient with predominantly liquid nodule~* Macro-calcifications in pre-focal HIFU path~* Nipple and or areola in pre-focal HIFU path~* Patient's fibroadenoma not clearly visible on the ultrasound images (in B-mode) at the inclusion visit~* Scars or moles before the focal point of the HIFU~* Patient participating in another clinical trial involving an investigational drug, or device

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- Surgery (Type: ACTIVE_COMPARATOR): Surgery
- HIFU (Echopulse) (Type: ACTIVE_COMPARATOR): HIFU (Echopulse)

Based on this trial design, predict the completion outcome and termination type (if applicable).